🦊/People

Mike Dybbs

InvestorUnicorn founder

Director & Co-founder at Kalaris Therapeutics, Inc. · Partner at Samsara BioCapital

Burlingame, California

Writes $10M – $100M checks · typically $25M

FoundedKalaris Therapeutics, Inc.$1.1B

Find your path to Mike

770 people in our graph share verified history with Mike — schools, employers, funds. One of them is your warm intro.

Adam ValkinunlockedMike: together at Harvard University (1993–1996)
×7Mike: together at University of California, Berkeley
×4Mike: together at Harvard University

Contact· self-published, not guessed

Experience

  1. Samsara BioCapitalPartnercurrent2017 — present
  2. Dimension TherapeuticsBoard of Directors2015 — 2017
  3. Principia BiopharmaBoard of Directors2014 — 2016
  4. Advanced Cell DiagnosticsBoard of Directors2012 — 2016
  5. New Leaf Venture PartnersPartner2009 — 2016
  6. Versartis, Inc.Board of Directors2013 — 2014
  7. The Boston Consulting GroupPrincipal2005 — 2009

Investments

Per curated public sources.

Colleagues at Samsara BioCapital

Frequently asked questions

Who is Mike Dybbs?
Partner at Samsara BioCapital
Where does Mike Dybbs work?
Mike Dybbs is Director & Co-founder of Kalaris Therapeutics, Inc. and Partner at Samsara BioCapital.
What check size does Mike Dybbs write?
Mike Dybbs typically writes checks of $10M – $100M.
What companies did Mike Dybbs found?
Mike Dybbs founded Kalaris Therapeutics, Inc..
What companies has Mike Dybbs invested in?
Investments tracked here include Advanced Cell Diagnostics, Arcellx, Claris Biotherapeutics, Dimension Therapeutics, IonPath, Nkarta Therapeutics, Principia Biopharma, Rayze Bio, Sutrobio, Versartis.
Where did Mike Dybbs go to school?
Mike Dybbs studied at University of California, Berkeley (PhD, Molecular and Cellular Biology); Harvard University (AB, Biochemical Sciences).

Same school

Shared employers